SHENG Bo,GU Huai-zhang,LI Long,TANG Geng,LIU Qi-bin.Bioactivity of SiO2/La2O3 Gradient Bioceramic Coating Fabricated by Laser Cladding[J],49(7):35-41
Bioactivity of SiO2/La2O3 Gradient Bioceramic Coating Fabricated by Laser Cladding
Received:July 04, 2020  Revised:July 20, 2020
View Full Text  View/Add Comment  Download reader
DOI:10.16490/j.cnki.issn.1001-3660.2020.07.005
KeyWord:SiO2  La2O3  HA  laser cladding  gradient bioceramic coating  bioactivity
              
AuthorInstitution
SHENG Bo 1.a.School of Materials and Metallurgy, Guizhou University, Guiyang , China
GU Huai-zhang 1.a.School of Materials and Metallurgy, Guizhou University, Guiyang , China
LI Long 1.a.School of Materials and Metallurgy, Guizhou University, Guiyang , China
TANG Geng 2.School of Mechanical and Electrical Engineering, Guizhou Normal University, Guiyang , China
LIU Qi-bin 1.a.School of Materials and Metallurgy, b.Key Laboratory for Modern Manufacturing Technology of the Ministry of Education, Guizhou University, Guiyang , China
Hits:
Download times:
Abstract:
      The work aims to study the effect of SiO2 content on the bioactivity of laser cladding gradient bioceramic coating on the titanium alloy. The coatings doped with different contents of SiO2 were fabricated on TC4 by laser cladding technology and design idea of gradient composition, with the fixed amount of rare earth oxide La2O3 in the coating. The effect of SiO2 content on the structure and bioactivity of laser cladding gradient coating was studied with OM, XRD, SEM, MTT and FDA. SiO2 could reduce the cracking sensitivity of the gradient bioceramic coating during the laser cladding and refine the grains. The coating with 2.5% SiO2 induced the most amount of HA+CaTiO3 during the laser cladding. The coating with 7.5% SiO2 demonstrated the strongest ability of mineralization and deposition in the simulated body fluid (SBF). The MTT test showed that the OD value of the proliferation number of cells in the coating with 7.5% SiO2 was the highest, and the cells could grow close to the coating surface. FDA staining analysis showed that the coating with 7.5% SiO2 had the largest number of cells and the cells were distributed evenly. The doping amount of SiO2 profoundly affects the amount of bioactive ceramic phase HA and Ca2SiO4, and further influences the bioactivity of bioceramic coating. The coating with 7.5% SiO2 possesses the best biocompatibility and bioactivity.
Close